Key recommendations for cervical cancer screening from the American College of Obstetricians and Gynecologists (ACOG) and the multidisciplinary partnership of the American Cancer Society, the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology.
Oct 13, 2020
The California Prevention Training Center (CAPTC) and the STI/HIV Prevention Program at the Hawaiʻi Department of Health’s (HIDOH) Harm Reduction Services Branch present this webinar for healthcare providers and community service providers who work with communities that face cultural, economic, and language barriers to obtaining good prenatal and neonatal care.
This webinar will address the increasing rate of syphilis cases within Hawaii, with a special focus on maternal syphilis and congenital syphilis. Learners will gain an understanding of the local epidemiology of syphilis as well as the important role the Hawaii Department of Health performs in syphilis case follow-up and investigation. An overview of the pathophysiology of syphilis with its varied clinical manifestations will be discussed. Content will include the importance of staging, stage-based treatment as well as best practices for diagnosis and follow-up.
Comprehensive professional tools, training, and patient resources for diagnosing and managing Hepatitis A, B, and C.
August 13, 2020
The coronavirus (COVID-19) is impacting the delivery of sexual health services in California and throughout the United States. Dr. Ina Park and Dr. Rosalyn Plotzker provide an overview of recent CDC recommendations for STD diagnosis and treatment when in-person exams and visits are limited. They also discuss best practices for the use of telehealth and home-testing for STD care and PrEP management.
Drs. Park and Plotzker cover the following learning objectives for this webinar:
July 23, 2020
The long-awaited new ASCCP Management Guideline App is now available, as well as the print version of the 2019 Guidelines. The new guidelines are streamlined for ease of use and can be significantly more individualized than the 2012 guidance by integrating information about an individual’s previous screening test and biopsy results, and personal factors such as age and immunosuppression. The guidelines now provide recommended follow up for all 3 available cervical screening strategies.
The following topics are covered in detail:
Learning objectives: At the end of this session, the learner will be able to:
Presenters:
Resources
June 1, 2020
Dr. Kenneth Katz covers the following learning objectives for this webinar:
March 24, 2020
This webinar features two new Family PACT Clinical Practice Alerts.
Cervical Cancer Screening
Topics in this portion of the webinar will include benefits through Family PACT that have been expanded to include high-risk HPV-alone screening, use of this test, alternative cervical cancer screening options, and new guidelines regarding cervical cancer screening for females who are HIV positive or who are immunocompromised.
Emergency Contraception
Topics in this portion of the webinar will include the relationship between body weight and emergency contraception failure rates, when oral contraceptives can be started with females who have used ulipristal acetate, options for accessing emergency contraceptive pills and the use of the copper IUD as emergency contraception.
Presenters:
Resources:
This document was created to enhance syphilis detection among people who are or could become pregnant (e.g. pregnant women and females of childbearing age) to prevent congenital syphilis (CS). Evidence-based recommendations in this document support policies and best practices intended to strengthen the response to the recent dramatic rise in CS incidence across California.
Please also see the associated Dear Colleage letter
Video example of a disease intervention interview linking a person co-infected with syphilis and HIV to care, and providing partner services.
June 20, 2019
Rates of sexually-transmitted diseases (STDs) such as chlamydia trachomatis (CT) and gonorrhea (GC) have reached an all-time high. In the U.S., California leads the nation in reported cases of these STDs. Because persons with CT and GC are often asymptomatic, screening is essential for the early detection and treatment that can prevent reproductive complications including pelvic inflammatory disease (PID), tubal infertility, ectopic pregnancy, and chronic pelvic pain in females and epididymitis in males.
This webinar covers current clinical guidelines for routine and targeted screening, treatment, follow-up, and prevention of CT and GC.
Learning objectives:
Presenters:
Resources:
